Chemomab Therapeutics Ltd. announced that Adi Mor, PhD, co-Founder and former Chief Executive Officer (CEO) of Chemomab, and current Director and Chief Scientific Officer, has been reappointed to the role of CEO, replacing Dale Pfost, PhD. All the appointments were effective June 1, 2023.